CYC technology diagnoses pulm embolus and chronic airways disease - esp early stage. Both often don't have anything to hear on examination of the lungs so won't be picked up by an 'app'.
Pulm embolus is life threatening - no room for error.
The App approach is more an aid to diagnosis.
Ann: Cyclopharm to Proceed Independently with FDA Trials-CYC.AX, page-30
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.005(0.50%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 99.0¢ | $82.99K | 83.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 23412 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 2308 | 1 |
View Market Depth
| Last trade - 14.49pm 18/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |